Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rosuvastatin 20mg + Clopidogrel 75mg Tablet
Therapeutic Category
Cardiovascular, Cardiology, Hypertension/ Blood Pressure
Dosage Form
Capsule
Packaging Type
Strip Pack
Packaging
10*10
Price
₹219/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rosumore CV 20/75 Capsule is a fixed-dose combination of Rosuvastatin 20mg, a statin, and Clopidogrel 75mg, an antiplatelet agent. This dual-action formulation helps in the management and prevention of cardiovascular events by lowering cholesterol levels and preventing blood clot formation. Rosuvastatin reduces LDL cholesterol and triglycerides while increasing HDL cholesterol. Clopidogrel inhibits platelet aggregation, reducing the risk of heart attacks and strokes. This combination is especially beneficial for patients at high risk of atherosclerotic cardiovascular disease.
Patients may experience muscle pain, headache, abdominal pain, dizziness, or nausea. Rare but serious effects include myopathy, liver enzyme elevation, or bleeding tendencies due to Clopidogrel. Regular liver function and lipid profile monitoring is advised.
Rosumore CV 20/75 Capsule is indicated for patients with dyslipidemia and a high risk of cardiovascular events such as heart attacks or strokes. It is also used for secondary prevention in patients with a history of myocardial infarction, stroke, or established peripheral arterial disease. The combination helps improve lipid profiles and reduce clot-related complications.
Use only under medical supervision. Not recommended in patients with active liver disease, bleeding disorders, or hypersensitivity to either component. Avoid alcohol and grapefruit juice during treatment.
Store at room temperature (below 25°C), away from moisture and sunlight. Keep out of reach of children.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Prazosin (2.5mg) Sustained Release Tablet
Composition : Prazosin (5 mg) Sustained Release
Composition : Metoprolol Succinate 100mg PR Tablet
Composition : Metoprolol 12.5 XL Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rosuvastatin 20 mg + Clopidogrel 75 mg Capsule is a cardiovascular combination therapy used for the prevention and management of heart attack, stroke, coronary artery disease, atherosclerosis, and other cardiovascular disorders associated with high cholesterol and blood clot formation. Rosuvastatin helps reduce LDL (bad cholesterol) and improve lipid profiles, while Clopidogrel acts as an antiplatelet agent that helps prevent blood clots. This combination is widely prescribed by cardiologists, physicians, and cardiac care specialists, making it a valuable product in the PCD pharma franchise and chronic cardiac care market.
Medical distributors and wholesalers can benefit from the strong and continuous demand for cardiovascular risk-reduction therapies. Since this combination is frequently prescribed for long-term management of cardiac patients, it generates regular repeat prescriptions, stable monthly sales, and consistent demand from hospitals, cardiac clinics, and retail pharmacies.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiovascular and cardiac care segment, including Rosuvastatin 20 mg + Clopidogrel 75 mg Capsule. We provide monopoly rights, quality-assured manufacturing, promotional support, and reliable product supply to help franchise partners establish a strong presence in the cardiac care market.
Wholesalers and stockists benefit from consistent prescription-driven demand, long-term patient usage, and strong acceptance among cardiologists and physicians. As cardiovascular disease management often requires ongoing therapy, this product offers steady product movement, recurring business opportunities, and sustainable profitability in pharmaceutical distribution.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and cardiac care products can contact Cafoli Lifecare to discuss pricing, product availability, monopoly franchise rights, and PCD pharma franchise opportunities. We provide complete support through marketing materials, dependable supply chains, and territory-based franchise assistance to help partners grow their business successfully.